Printed from Voxsanity (voxsanity.com.au) — NCT07200154 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Lung Cancer
Phase 2 Lung Cancer Trial, Not Yet Recruiting
NCT07200154
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 to 75 years of any sex, whose lung cancer has been confirmed by laboratory testing of tissue or cells, and who have been diagnosed with a specific type and stage of lung cancer called limited-stage small-cell lung cancer (LS-SCLC).
- People who have either stored tumour tissue samples (a block or slides from a previous biopsy) available, or who are able to provide a new biopsy from an area that has not been treated with radiation before.
- People who have had no more than 2 cycles of chemotherapy before joining, or who have never received chemotherapy, and who have a good general level of physical functioning as measured by a standard medical scale (ECOG score of 0 or 1).
- People who have at least one tumour that can be measured on a CT scan, meeting specific size requirements (at least 10 mm for most tumours, or at least 15 mm for tumours in the lymph nodes).
- People whose doctors estimate they are likely to live for at least 3 more months, and whose lung function is considered adequate by the medical team.
- People whose blood and organ function results meet specific levels, including healthy enough red blood cells, white blood cells, and platelets, as well as adequate liver and kidney function (confirm specific values with the trial site).
- Women who could become pregnant must have a negative pregnancy test within 14 days before joining, and must use effective contraception from the screening period until at least 8 weeks after the last study treatment; men must either have had a surgical procedure to prevent fathering children or agree to use effective contraception during the same period.
- People who are willing and able to give informed consent, follow all study procedures, and attend follow-up appointments.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously had a solid organ transplant, a donor stem cell transplant, or who have a transplant planned.
- People who have used medicines that suppress the immune system within 14 days before the first study treatment (with some exceptions for low-dose or inhaled/nasal steroid medications — confirm with trial site).
- People who have a known allergy to any of the study drugs (etoposide, cisplatin, or adebrelimab), their ingredients, or who have had a severe allergic reaction to any similar antibody-based medicine.
- People who have received a live vaccine within 4 weeks before starting the study, or who plan to receive one during the study.
- People who have an active autoimmune disease, or a history of certain autoimmune conditions such as autoimmune hepatitis, inflammatory lung disease, colitis, or thyroid disorders (confirm full list with trial site).
- People with asthma that is currently not well controlled and requires ongoing medication; however, people who had childhood asthma that fully resolved and requires no treatment as an adult may still be eligible (confirm with trial site).
- People whose urine tests show a significant level of protein, above certain thresholds (confirm specific values with trial site).
- People who have had another cancer in the past, except for certain treated skin cancers or early-stage cervical cancer that has been adequately treated.
- People who have HIV infection or a known diagnosis of AIDS.
- People who have had a heart attack, severe chest pain, significant heart failure, poorly controlled irregular heartbeat, or other serious heart problems within the 6 months before joining.
- People who have required treatment with intravenous antibiotics, antifungal, or antiviral medicines within 4 weeks before the first study treatment, or who have had an unexplained high fever during the screening period.
- People with active hepatitis B or hepatitis C infections, or both at the same time, based on specific blood test results (confirm with trial site).
- People who have taken part in another interventional clinical trial within 4 weeks before the first study treatment.
- People with a known history of substance abuse or recreational drug use.
- People with any serious medical, psychiatric, or laboratory condition that the trial doctor believes could increase risks or affect study results.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Contact this trial
Phone: 010-8819 6984
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Peking University Cancer Hospital & Institute
Registry
ClinicalTrials.gov
Start date
30 September 2025
Est. completion
30 March 2028
Where this trial is recruiting
🇨🇳 China
Primary endpoints
PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.